CMS is set to conduct a National Provider Call on Wednesday to discuss the final stage 2 meaningful use rule and changes in federal incentive programs.
Published in Brief:
Attest Health Care Advisors
|Director, Corporate Counsel - Regulatory Law||
|Active Implantable Medical Device (AIMD) Product Expert||
|Vice President of Finance||
Urban Health Plan, Inc.
|Finance Manager - ENT||